Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 4Carcinoma, Hepatocellular 4Rectal Neoplasms 3Esophageal Neoplasms 3Uterine Cervical Neoplasms 2Stomach Neoplasms 2Neoplasms 2Colonic Neoplasms 2Prostatic Neoplasms 1Pancreatic Cystic Neoplasms 1Melanoma 1Lymphoma 1Lung Neoplasms 1Liver Neoplasms 1Liver Cirrhosis 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Esophagogastric Cancer 1Endometrial Neoplasms 1Biliary Tract Neoplasms 1Anus Neoplasms 1

Interventions

Sorafenib 68Bevacizumab 44Oxaliplatin 25Doxorubicin 22Gemcitabine 21Fluorouracil 21Radiosurgery 20Nivolumab 19durvalumab 18Radiofrequency Ablation 18pembrolizumab 17lenvatinib 17Cisplatin 17Capecitabine 17atezolizumab 14Leucovorin 14Hepatectomy 14Radiotherapy 12tremelimumab 10Irinotecan 10Drug Therapy 10Cyclophosphamide 10Carboplatin 10Blood Specimen Collection 10Ipilimumab 9regorafenib 8Liver Transplantation 8Everolimus 8Cryosurgery 8Chemotherapy, Adjuvant 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Liver Neoplasms × Positron-Emission Tomography × Gastrointestinal × Clear all
NCT02018107 2020-03-26

PET/CT-Assessment of Liver Tumor Ablation

Dana-Farber Cancer Institute

Phase NA Completed
33 enrolled 5 charts
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡